Nexgel (NXGL) Capital Expenditures (2020 - 2025)
Nexgel (NXGL) has disclosed Capital Expenditures for 6 consecutive years, with $8000.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Capital Expenditures fell 38.46% year-over-year to $8000.0, compared with a TTM value of $299000.0 through Sep 2025, down 34.86%, and an annual FY2024 reading of $443000.0, down 36.35% over the prior year.
- Capital Expenditures was $8000.0 for Q3 2025 at Nexgel, down from $69000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $358000.0 in Q3 2023 and bottomed at -$121000.0 in Q4 2021.
- Average Capital Expenditures over 5 years is $100800.0, with a median of $85000.0 recorded in 2023.
- Peak annual rise in Capital Expenditures hit 26600.0% in 2021, while the deepest fall reached 175.62% in 2021.
- Year by year, Capital Expenditures stood at -$121000.0 in 2021, then soared by 106.61% to $8000.0 in 2022, then soared by 962.5% to $85000.0 in 2023, then decreased by 18.82% to $69000.0 in 2024, then tumbled by 88.41% to $8000.0 in 2025.
- Business Quant data shows Capital Expenditures for NXGL at $8000.0 in Q3 2025, $69000.0 in Q4 2024, and $13000.0 in Q3 2024.